Complete List of Monoclonal antibody (IL-13 inhibitor) Medicines
Brand: DUPIXENT |
Strength: 200 mg |
Form: Solution For Injection
Class: | Monoclonal antibody (IL-4 and IL-13 inhibitor)
Use: | Treatment of moderate to severe asthma, atopic dermatitis (eczema), chronic rhinosinusitis with nasal polyps, and eosinophilic esophagi...
Brand: DUPIXENT |
Strength: 200 mg |
Form: Solution For Injection
Class: | Monoclonal antibody (IL-4 and IL-13 inhibitor)
Use: | Treatment of moderate to severe asthma, atopic dermatitis (eczema), chronic rhinosinusitis with nasal polyps, and eosinophilic esophagi...
Brand: DUPIXENT |
Strength: 200 mg/1.14ml |
Form: Solution For Injection
Class: | Monoclonal antibody (IL-4 and IL-13 inhibitor)
Use: | Indicated for the treatment of moderate to severe asthma, chronic rhinosinusitis with nasal polyps, atopic dermatitis, and eosinophilic...
Brand: DUPIXENT |
Strength: 300 mg |
Form: Solution For Injection
Class: | Monoclonal antibody (IL-4 and IL-13 inhibitor)
Use: | Treatment of moderate to severe asthma, chronic rhinosinusitis with nasal polyps, atopic dermatitis, and eosinophilic esophagitis
Adu...
Brand: DUPIXENT |
Strength: 300 mg/2ml |
Form: Solution For Injection
Class: | Monoclonal antibody (IL-4 and IL-13 inhibitor)
Use: | Treatment of moderate to severe asthma, chronic rhinosinusitis with nasal polyps, atopic dermatitis, and eosinophilic esophagitis
Adu...
Brand: Ebglyss 250 mg per 2ml |
Strength: 250 mg/2ml |
Form: Solution For Injection
Class: | Monoclonal antibody (IL-13 inhibitor)
Use: | Treatment of moderate to severe atopic dermatitis in adults and pediatric patients aged 12 years and older who are candidates for systemic thera...
Brand: ADTRALZA |
Strength: 150 mg/ml |
Form: Solution For Injection
Class: | Monoclonal antibody (IL-13 inhibitor)
Use: | Treatment of moderate to severe atopic dermatitis in adults and pediatric patients aged 6 years and older
Adult dose: | Initial dose: 600 mg (...